Research Article
Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway
Table 4
Other identified drug-drug interactions involving antiepileptic drugs in patients ≥65 years receiving home cares services or living in nursing homes.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Caused by combination with AED enzyme inducers or inhibitors causing a decrease in serum concentration and lack of efficacy of the affected drug or an increase in serum concentration and excessive adverse effects or toxicity, respectively. With other CNS-active drugs resulting in a possibility for excessive adverse effects and sedation. Increased excretion of sodium and increased risk of hyponatremia with carbamazepine. Also a pharmacokinetic interaction and included in Table 3. |